Global Opioids Agonist Drugs Market Research Report 2020

Global Opioids Agonist Drugs Market Research Report 2020

Table of Contents
1 Opioids Agonist Drugs Market Overview
1.1 Product Overview and Scope of Opioids Agonist Drugs
1.2 Opioids Agonist Drugs Segment by Type
1.2.1 Global Opioids Agonist Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Codeine
1.2.3 Fentanyl
1.2.4 Meperidine
1.2.5 Methadone
1.2.6 Morphine
1.2.7 Hydrocodone
1.3 Opioids Agonist Drugs Segment by Application
1.3.1 Opioids Agonist Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Pain Management
1.3.3 Cough Treatment
1.3.4 Diarrhea Treatment
1.4 Global Opioids Agonist Drugs Market Size Estimates and Forecasts
1.4.1 Global Opioids Agonist Drugs Revenue 2015-2026
1.4.2 Global Opioids Agonist Drugs Sales 2015-2026
1.4.3 Opioids Agonist Drugs Market Size by Region: 2020 Versus 2026
2 Global Opioids Agonist Drugs Market Competition by Manufacturers
2.1 Global Opioids Agonist Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Opioids Agonist Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Opioids Agonist Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Opioids Agonist Drugs Manufacturing Sites, Area Served, Product Type
2.5 Opioids Agonist Drugs Market Competitive Situation and Trends
2.5.1 Opioids Agonist Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Opioids Agonist Drugs Players (Opinion Leaders)
3 Opioids Agonist Drugs Retrospective Market Scenario by Region
3.1 Global Opioids Agonist Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Opioids Agonist Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Opioids Agonist Drugs Market Facts & Figures by Country
3.3.1 North America Opioids Agonist Drugs Sales by Country
3.3.2 North America Opioids Agonist Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Opioids Agonist Drugs Market Facts & Figures by Country
3.4.1 Europe Opioids Agonist Drugs Sales by Country
3.4.2 Europe Opioids Agonist Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Opioids Agonist Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Opioids Agonist Drugs Sales by Region
3.5.2 Asia Pacific Opioids Agonist Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Opioids Agonist Drugs Market Facts & Figures by Country
3.6.1 Latin America Opioids Agonist Drugs Sales by Country
3.6.2 Latin America Opioids Agonist Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Opioids Agonist Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Opioids Agonist Drugs Sales by Country
3.7.2 Middle East and Africa Opioids Agonist Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Opioids Agonist Drugs Historic Market Analysis by Type
4.1 Global Opioids Agonist Drugs Sales Market Share by Type (2015-2020)
4.2 Global Opioids Agonist Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Opioids Agonist Drugs Price Market Share by Type (2015-2020)
4.4 Global Opioids Agonist Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Opioids Agonist Drugs Historic Market Analysis by Application
5.1 Global Opioids Agonist Drugs Sales Market Share by Application (2015-2020)
5.2 Global Opioids Agonist Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Opioids Agonist Drugs Price by Application (2015-2020)
6 Company Profiles and Key Figures in Opioids Agonist Drugs Business
6.1 Purdue Pharma
6.1.1 Corporation Information
6.1.2 Purdue Pharma Description, Business Overview and Total Revenue
6.1.3 Purdue Pharma Opioids Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Purdue Pharma Products Offered
6.1.5 Purdue Pharma Recent Development
6.2 Titan pharmaceuticals
6.2.1 Titan pharmaceuticals Opioids Agonist Drugs Production Sites and Area Served
6.2.2 Titan pharmaceuticals Description, Business Overview and Total Revenue
6.2.3 Titan pharmaceuticals Opioids Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Titan pharmaceuticals Products Offered
6.2.5 Titan pharmaceuticals Recent Development
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Opioids Agonist Drugs Production Sites and Area Served
6.3.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
6.3.3 Boehringer Ingelheim Opioids Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Boehringer Ingelheim Products Offered
6.3.5 Boehringer Ingelheim Recent Development
6.4 Janssen Pharmaceuticals, Inc
6.4.1 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Production Sites and Area Served
6.4.2 Janssen Pharmaceuticals, Inc Description, Business Overview and Total Revenue
6.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Janssen Pharmaceuticals, Inc Products Offered
6.4.5 Janssen Pharmaceuticals, Inc Recent Development
6.5 Sanofi
6.5.1 Sanofi Opioids Agonist Drugs Production Sites and Area Served
6.5.2 Sanofi Description, Business Overview and Total Revenue
6.5.3 Sanofi Opioids Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Sanofi Products Offered
6.5.5 Sanofi Recent Development
6.6 Sun Pharmaceuticals
6.6.1 Sun Pharmaceuticals Opioids Agonist Drugs Production Sites and Area Served
6.6.2 Sun Pharmaceuticals Description, Business Overview and Total Revenue
6.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Sun Pharmaceuticals Products Offered
6.6.5 Sun Pharmaceuticals Recent Development
6.7 Mallinckrodt Pharmaceuticals
6.6.1 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Production Sites and Area Served
6.6.2 Mallinckrodt Pharmaceuticals Description, Business Overview and Total Revenue
6.6.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Mallinckrodt Pharmaceuticals Products Offered
6.7.5 Mallinckrodt Pharmaceuticals Recent Development
6.8 Egalet Corporation
6.8.1 Egalet Corporation Opioids Agonist Drugs Production Sites and Area Served
6.8.2 Egalet Corporation Description, Business Overview and Total Revenue
6.8.3 Egalet Corporation Opioids Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Egalet Corporation Products Offered
6.8.5 Egalet Corporation Recent Development
6.9 Endo Pharmaceuticals Inc.
6.9.1 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Production Sites and Area Served
6.9.2 Endo Pharmaceuticals Inc. Description, Business Overview and Total Revenue
6.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Endo Pharmaceuticals Inc. Products Offered
6.9.5 Endo Pharmaceuticals Inc. Recent Development
6.10 Allergan, Plc
6.10.1 Allergan, Plc Opioids Agonist Drugs Production Sites and Area Served
6.10.2 Allergan, Plc Description, Business Overview and Total Revenue
6.10.3 Allergan, Plc Opioids Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Allergan, Plc Products Offered
6.10.5 Allergan, Plc Recent Development
6.11 Pfizer Inc
6.11.1 Pfizer Inc Opioids Agonist Drugs Production Sites and Area Served
6.11.2 Pfizer Inc Opioids Agonist Drugs Description, Business Overview and Total Revenue
6.11.3 Pfizer Inc Opioids Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Pfizer Inc Products Offered
6.11.5 Pfizer Inc Recent Development
7 Opioids Agonist Drugs Manufacturing Cost Analysis
7.1 Opioids Agonist Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Opioids Agonist Drugs
7.4 Opioids Agonist Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Opioids Agonist Drugs Distributors List
8.3 Opioids Agonist Drugs Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Opioids Agonist Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Opioids Agonist Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Opioids Agonist Drugs by Type (2021-2026)
10.2 Opioids Agonist Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Opioids Agonist Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Opioids Agonist Drugs by Application (2021-2026)
10.3 Opioids Agonist Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Opioids Agonist Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Opioids Agonist Drugs by Region (2021-2026)
10.4 North America Opioids Agonist Drugs Estimates and Projections (2021-2026)
10.5 Europe Opioids Agonist Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Opioids Agonist Drugs Estimates and Projections (2021-2026)
10.7 Latin America Opioids Agonist Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Opioids Agonist Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Opioids Agonist Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Opioids Agonist Drugs Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Opioids Agonist Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Opioids Agonist Drugs Manufacturers Covered in This Study
Table 5. Global Opioids Agonist Drugs Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Opioids Agonist Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Opioids Agonist Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Opioids Agonist Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Opioids Agonist Drugs Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Opioids Agonist Drugs Sales Sites and Area Served
Table 11. Manufacturers Opioids Agonist Drugs Product Types
Table 12. Global Opioids Agonist Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Opioids Agonist Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids Agonist Drugs as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Opioids Agonist Drugs Players
Table 16. Global Opioids Agonist Drugs Sales (K Units) by Region (2015-2020)
Table 17. Global Opioids Agonist Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Opioids Agonist Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Opioids Agonist Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Opioids Agonist Drugs Sales by Country (2015-2020) (K Units)
Table 21. North America Opioids Agonist Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Opioids Agonist Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Opioids Agonist Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Opioids Agonist Drugs Sales by Country (2015-2020) (K Units)
Table 25. Europe Opioids Agonist Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Opioids Agonist Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Opioids Agonist Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Opioids Agonist Drugs Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Opioids Agonist Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Opioids Agonist Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Opioids Agonist Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Opioids Agonist Drugs Sales by Country (2015-2020) (K Units)
Table 33. Latin America Opioids Agonist Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Opioids Agonist Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Opioids Agonist Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Opioids Agonist Drugs Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Opioids Agonist Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Opioids Agonist Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Opioids Agonist Drugs Sales (K Units) by Type (2015-2020)
Table 41. Global Opioids Agonist Drugs Sales Share by Type (2015-2020)
Table 42. Global Opioids Agonist Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Opioids Agonist Drugs Revenue Share by Type (2015-2020)
Table 44. Global Opioids Agonist Drugs Price (USD/Unit) by Type (2015-2020)
Table 45. Global Opioids Agonist Drugs Sales (K Units) by Application (2015-2020)
Table 46. Global Opioids Agonist Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Opioids Agonist Drugs Sales Growth Rate by Application (2015-2020)
Table 48. Purdue Pharma Opioids Agonist Drugs Corporation Information
Table 49. Purdue Pharma Description and Business Overview
Table 50. Purdue Pharma Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Purdue Pharma Main Product
Table 52. Purdue Pharma Recent Development
Table 53. Titan pharmaceuticals Opioids Agonist Drugs Corporation Information
Table 54. Titan pharmaceuticals Corporation Information
Table 55. Titan pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Titan pharmaceuticals Main Product
Table 57. Titan pharmaceuticals Recent Development
Table 58. Boehringer Ingelheim Opioids Agonist Drugs Corporation Information
Table 59. Boehringer Ingelheim Corporation Information
Table 60. Boehringer Ingelheim Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Boehringer Ingelheim Main Product
Table 62. Boehringer Ingelheim Recent Development
Table 63. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Corporation Information
Table 64. Janssen Pharmaceuticals, Inc Corporation Information
Table 65. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Janssen Pharmaceuticals, Inc Main Product
Table 67. Janssen Pharmaceuticals, Inc Recent Development
Table 68. Sanofi Opioids Agonist Drugs Corporation Information
Table 69. Sanofi Corporation Information
Table 70. Sanofi Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Sanofi Main Product
Table 72. Sanofi Recent Development
Table 73. Sun Pharmaceuticals Opioids Agonist Drugs Corporation Information
Table 74. Sun Pharmaceuticals Corporation Information
Table 75. Sun Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Sun Pharmaceuticals Main Product
Table 77. Sun Pharmaceuticals Recent Development
Table 78. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Corporation Information
Table 79. Mallinckrodt Pharmaceuticals Corporation Information
Table 80. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Mallinckrodt Pharmaceuticals Main Product
Table 82. Mallinckrodt Pharmaceuticals Recent Development
Table 83. Egalet Corporation Opioids Agonist Drugs Corporation Information
Table 84. Egalet Corporation Corporation Information
Table 85. Egalet Corporation Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Egalet Corporation Main Product
Table 87. Egalet Corporation Recent Development
Table 88. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Corporation Information
Table 89. Endo Pharmaceuticals Inc. Corporation Information
Table 90. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Endo Pharmaceuticals Inc. Main Product
Table 92. Endo Pharmaceuticals Inc. Recent Development
Table 93. Allergan, Plc Opioids Agonist Drugs Corporation Information
Table 94. Allergan, Plc Corporation Information
Table 95. Allergan, Plc Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Allergan, Plc Main Product
Table 97. Allergan, Plc Recent Development
Table 98. Pfizer Inc Opioids Agonist Drugs Corporation Information
Table 99. Pfizer Inc Corporation Information
Table 100. Pfizer Inc Opioids Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Pfizer Inc Main Product
Table 102. Pfizer Inc Recent Development
Table 103. Sales Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Opioids Agonist Drugs Distributors List
Table 106. Opioids Agonist Drugs Customers List
Table 107. Market Key Trends
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Global Opioids Agonist Drugs Sales (K Units) Forecast by Type (2021-2026)
Table 111. Global Opioids Agonist Drugs Sales Market Share Forecast by Type (2021-2026)
Table 112. Global Opioids Agonist Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 113. Global Opioids Agonist Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 114. Global Opioids Agonist Drugs Sales (K Units) Forecast by Application (2021-2026)
Table 115. Global Opioids Agonist Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 116. Global Opioids Agonist Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 117. Global Opioids Agonist Drugs Sales Market Share Forecast by Region (2021-2026)
Table 118. Global Opioids Agonist Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Global Opioids Agonist Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Opioids Agonist Drugs
Figure 2. Global Opioids Agonist Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Codeine Product Picture
Figure 4. Fentanyl Product Picture
Figure 5. Meperidine Product Picture
Figure 6. Methadone Product Picture
Figure 7. Morphine Product Picture
Figure 8. Hydrocodone Product Picture
Figure 9. Global Opioids Agonist Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 10. Pain Management
Figure 11. Cough Treatment
Figure 12. Diarrhea Treatment
Figure 13. Global Opioids Agonist Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Opioids Agonist Drugs Sales Capacity (K Units) (2015-2026)
Figure 15. Global Opioids Agonist Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Opioids Agonist Drugs Sales Share by Manufacturers in 2020
Figure 17. Global Opioids Agonist Drugs Revenue Share by Manufacturers in 2019
Figure 18. The Global 5 and 10 Largest Players: Market Share by Opioids Agonist Drugs Revenue in 2019
Figure 19. Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Opioids Agonist Drugs Sales Market Share by Region (2015-2020)
Figure 21. Global Opioids Agonist Drugs Sales Market Share by Region in 2019
Figure 22. Global Opioids Agonist Drugs Revenue Market Share by Region (2015-2020)
Figure 23. Global Opioids Agonist Drugs Revenue Market Share by Region in 2019
Figure 24. North America Opioids Agonist Drugs Sales Market Share by Country in 2019
Figure 25. North America Opioids Agonist Drugs Revenue Market Share by Country in 2019
Figure 26. U.S. Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 27. U.S. Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Canada Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 29. Canada Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. Europe Opioids Agonist Drugs Sales Market Share by Country in 2019
Figure 31. Europe Opioids Agonist Drugs Revenue Market Share by Country in 2019
Figure 32. Germany Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. Germany Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. France Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. France Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. U.K. Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.K. Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Italy Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. Italy Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Russia Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. Russia Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Asia Pacific Opioids Agonist Drugs Sales Market Share by Region in 2019
Figure 43. Asia Pacific Opioids Agonist Drugs Revenue Market Share by Region in 2019
Figure 44. China Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. China Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Japan Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. Japan Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. South Korea Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. South Korea Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. India Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. India Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Australia Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Australia Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Taiwan Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Taiwan Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Indonesia Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. Indonesia Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Thailand Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. Thailand Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Malaysia Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. Malaysia Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Philippines Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. Philippines Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Vietnam Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. Vietnam Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Latin America Opioids Agonist Drugs Sales Market Share by Country in 2019
Figure 67. Latin America Opioids Agonist Drugs Revenue Market Share by Country in 2019
Figure 68. Mexico Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Mexico Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Brazil Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Brazil Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Argentina Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Middle East and Africa Opioids Agonist Drugs Sales Market Share by Country in 2019
Figure 75. Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Country in 2019
Figure 76. Turkey Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Saudi Arabia Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Saudi Arabia Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. U.A.E Opioids Agonist Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. U.A.E Opioids Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Sales Market Share of Opioids Agonist Drugs by Type (2015-2020)
Figure 83. Sales Market Share of Opioids Agonist Drugs by Type in 2019
Figure 84. Revenue Share of Opioids Agonist Drugs by Type (2015-2020)
Figure 85. Revenue Market Share of Opioids Agonist Drugs by Type in 2019
Figure 86. Global Opioids Agonist Drugs Sales Growth by Type (2015-2020) (K Units)
Figure 87. Global Opioids Agonist Drugs Sales Market Share by Application (2015-2020)
Figure 88. Global Opioids Agonist Drugs Sales Market Share by Application in 2019
Figure 89. Global Revenue Share of Opioids Agonist Drugs by Application (2015-2020)
Figure 90. Global Revenue Share of Opioids Agonist Drugs by Application in 2020
Figure 91. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Titan pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Janssen Pharmaceuticals, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Sun Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Mallinckrodt Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Egalet Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Endo Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Allergan, Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Pfizer Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Price Trend of Key Raw Materials
Figure 103. Manufacturing Cost Structure of Opioids Agonist Drugs
Figure 104. Manufacturing Process Analysis of Opioids Agonist Drugs
Figure 105. Opioids Agonist Drugs Industrial Chain Analysis
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Porter's Five Forces Analysis
Figure 109. North America Opioids Agonist Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. North America Opioids Agonist Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Europe Opioids Agonist Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Europe Opioids Agonist Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Latin America Opioids Agonist Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Latin America Opioids Agonist Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Middle East and Africa Opioids Agonist Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 116. Middle East and Africa Opioids Agonist Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Asia Pacific Opioids Agonist Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 118. Asia Pacific Opioids Agonist Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs